Collaboration between industry, academia, and research institutions, as well as domestic and international technology exchange and cooperation.
Established 2 cross-disciplinary cooperative laboratories. Collaborated with the Air Force Medical University, the Institute of System Medicine of the Chinese Academy of Medical Sciences, Soochow University, Suzhou Municipal Hospital, the Fifth People’s Hospital of Shanghai, and several dozen innovative biopharmaceutical companies (such as Junshi Biosciences, Hengrui Medicine, Kaitai Pharmaceutical, Suzhou Yuet Kang, Suzhou Luosheng, and Suzhou InteRx Pharmaceuticals) on project cooperation. Promoted the establishment of the XJTLU-Liverpool University Joint Pharmacology and Therapy Center, and undertook one of the four main topics of the center (clinical biomarker and drug target discovery for neurodegenerative diseases); established cooperation with the Proteomics Center of Purdue University in the United States.
Open Service Content (refers to the platform providing various technical services to external units):
High-throughput proteomics (drug target and biomarker discovery)
Protein identification
High-throughput quantitative proteomics
Targeted proteomics
Protein translational modifications (drug mechanism research, target and biomarker discovery and confirmation)
Qualitative analysis of modified proteins
Quantitative analysis of modified proteins
Bioinformatics and data services (drug mechanism , target and biomarker discovery)
Quality control analysis
Functional annotation analysis
Personalized biological analysis
Protein characterization analysis (drug mechanism , QA/QC)
Characterization for large and small molecule drugs
Collaboration between industry, academia, and research institutions, as well as domestic and international technology exchange and cooperation.
Established 2 cross-disciplinary cooperative laboratories. Collaborated with the Air Force Medical University, the Institute of System Medicine of the Chinese Academy of Medical Sciences, Soochow University, Suzhou Municipal Hospital, the Fifth People’s Hospital of Shanghai, and several dozen innovative biopharmaceutical companies (such as Junshi Biosciences, Hengrui Medicine, Kaitai Pharmaceutical, Suzhou Yuet Kang, Suzhou Luosheng, and Suzhou InteRx Pharmaceuticals) on project cooperation. Promoted the establishment of the XJTLU-Liverpool University Joint Pharmacology and Therapy Center, and undertook one of the four main topics of the center (clinical biomarker and drug target discovery for neurodegenerative diseases); established cooperation with the Proteomics Center of Purdue University in the United States.
Open Service Content (refers to the platform providing various technical services to external units):
High-throughput proteomics (drug target and biomarker discovery)
Protein translational modifications (drug mechanism research, target and biomarker discovery and confirmation)
Bioinformatics and data services (drug mechanism , target and biomarker discovery)
Protein characterization analysis (drug mechanism , QA/QC)
Enzyme-linked immunosorbent assay (ELISA) (PK Assays)
Molecular interaction analysis
Flow cytometry analysis
Metabolomics and lipidomics (pharmacological and toxicological analysis)